Cell cycle dysregulation in breast cancer - the roles of Jab1 and Archipelago.

被引：0
|
作者：
Bonner, SE [1 ]
Morris, DG [1 ]
Korbonits, M [1 ]
Laban, CA [1 ]
McCarthy, K [1 ]
Al-Mufti, R [1 ]
Grossman, AB [1 ]
Carpenter, R [1 ]
机构：
[1] St Bartholomews Hosp, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway
    Zhu, Yufu
    Qiu, Zhichao
    Zhang, Xiang
    Qian, Fengyuan
    Wang, Bin
    Wang, Lei
    Shi, Hengliang
    Yu, Rutong
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) : 31 - 39
  • [42] Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer
    Vu, Thuy T.
    Shackleford, Terry
    Zhang, Qingxiu
    Oh, Do-Youn
    Zhou Fuling
    Pan, Yunbao
    Tian, Ling
    Drakos, Ilias
    Rassidakis, Georgios
    Le, Xiao-Feng
    Sahin, Aysegul
    Kute, Timothy
    Claret, Francois
    CANCER RESEARCH, 2012, 72
  • [43] Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells
    Nishimoto, Arata
    Takemoto, Yoshihiro
    Saito, Toshiro
    Kurazumi, Hiroshi
    Tanaka, Toshiki
    Harada, Eijiro
    Shirasawa, Bungo
    Hamano, Kimikazu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (03) : 548 - 552
  • [44] Jab1/Csn5 a new target in the resistant mechanism to HER2-targeted therapies for breast cancer
    Claret, Francois X.
    Thuy Vu
    Shackleford, Terry J.
    Allensworth, Jennifer
    Zhang, Qingxiu
    Tian, Ling
    Zhang, Ronghua
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Study to Elucidate the Inhibitory Potential of Selected Flavonoids against Jab1 in Cervical Cancer
    Maurya, Pooja
    Pandey, Pratibha
    Khan, Fahad
    Mishra, Rashmi
    Chaudhary, Rohit
    Singh, Sujeet Kumar
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2022, 12 (01): : 1290 - 1303
  • [46] HER-2/neu transcriptionally activates Jab1 expression via the AKT/β-catenin pathway in breast cancer cells
    Hsu, Ming-Chuan
    Chang, Hui-Chiu
    Hung, Wen-Chun
    ENDOCRINE-RELATED CANCER, 2007, 14 (03) : 655 - 667
  • [47] Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzurnab in Her2-positive Breast Cancer
    Vu, T.
    Zhang, Q.
    Tian, L.
    Shackleford, T.
    Kute, T.
    Claret, F. X.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 155 - 155
  • [48] Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer
    Claret, F.
    Vu, T.
    Shackleford, T. J.
    Allensworth, J. L.
    Zhang, Q.
    Esteva, F. J.
    Drakos, E.
    Zhang, R.
    Tian, L.
    Rassidakis, G. Z.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 155 - 155
  • [49] Cell cycle dysregulation in oral cancer
    Todd, R
    Hinds, PW
    Munger, K
    Rustgi, AK
    Opitz, OG
    Suliman, Y
    Wong, DT
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (01) : 51 - 61
  • [50] CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin
    Li, Jie
    Li, Yingjie
    Wang, Bin
    Ma, Yongfu
    Chen, Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (02) : 132 - 138
12345